AI Article Synopsis
- - The COVID-19 pandemic causes severe lung damage primarily due to a systemic inflammatory response triggered by the body's immune cells rather than the virus itself.
- - This meta-analysis aimed to explore the connection between high sodium levels (hypernatremia) and mortality rates in COVID-19 patients by reviewing various research articles.
- - Findings from nine studies revealed that hypernatremia significantly increases the risk of death among COVID-19 patients, with mortality rates of 42% in those with hypernatremia versus 15% in those without.
Article Abstract
Background: The COVID-19 pandemic worldwide has caused varying degrees of severity of lung damage in patients, with acute respiratory distress and death in severe cases. However, this is not directly caused by the virus itself, but by the production of inflammasome by monocytes in the body, leading to a systemic inflammatory response, which results in a very poor clinical prognosis for patients with COVID-19.
Objective: The purpose of this meta-analysis was to look at the relationship between hypernatremia and mortality in COVID-19 patients.
Methods: We searched the PubMed, Web of Science, Embase, and Cochrane databases for articles published from the inception of the database until August 27, 2022. Three researchers reviewed the literature, retrieved data, and assessed the quality of the literature, respectively. A meta-analysis was performed using State 17 software to assess the value of the effect of hypernatremia on mortality in patients with new coronavirus pneumonia.
Results: A total of nine publications was finally included in this study, including a total of 11,801 patients with COVID-19, including 1278 in the hypernatremia group and 10,523 in the normonatremia group. Meta-analysis showed that hypernatremia was associated with mortality in patients with COVID-19 [OR = 4.15, 95% CI (2.95-5.84), p = .002, I² = 66.7%] with a sensitivity of 0.36 [0.26, 0.48] and a specificity of 0.88 [0.83, 0.91]. The posterior probability of mortality was 42% in patients with COVID-19 hypernatremia and 15% in patients who did not have COVID-19 hypernatremia.
Conclusion: According to available data, hypernatremia is associated with death in patients with COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714304 | PMC |
| http://dx.doi.org/10.1002/iid3.1109 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!